Journal of Neurology

, Volume 260, Issue 4, pp 1166–1167 | Cite as

Unmasking of incipient amyotrophic lateral sclerosis by botulinum toxin therapy

  • Louisa Kent
  • Paul Davies
  • Robin Kennett
  • Sunil Wimalaratna
  • Richard Kerr
  • Martin R. Turner
  • Kevin Talbot
Letter to the Editors

Keywords

Amyotrophic Lateral Sclerosis Dystonia Botulinum Toxin Onyx Plantar Flexor 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Notes

Conflicts of interest

On behalf of all authors, the corresponding author states that there is no conflict of interest.

Ethical standard

The authors declare that they acted in accordance with the ethical standards laid down in the 1964 Declaration of Helsinki.

References

  1. 1.
    Tan E, Lo Y, Auchus A (2001) Recurrent jaw dislocation after botulinum toxin treatment for sialorrhoea in amyotrophic lateral sclerosis. J Neurol Sci 190(1–2):95–97PubMedCrossRefGoogle Scholar
  2. 2.
    Winterholler M, Erbguth F (2001) Botulinum toxin for the treatment of sialorrhoea in ALS: serious side effects of a transductal approach. JNNP 70:417–418Google Scholar
  3. 3.
    Meijer J, van Kuijk A, Zwarts M (2008) Acute deterioration of bulbar function after botulinum toxin treatment for sialorrhoea in amyotrophic lateral sclerosis. Am J Phys Med Rehabil 87(4):321–324PubMedCrossRefGoogle Scholar
  4. 4.
    Erbguth F, Claus D, Engelhardt A, Dressler D (1993) Systemic effect of local botulinum toxin injections unmasks subclinical Lambert–Eaton myasthenic syndrome. JNNP 56(11):1235–1236Google Scholar
  5. 5.
    Dressler D (2010) Subclinical myasthenia gravis causing increased sensitivity to botulinum toxin therapy. J Neural Transm 117:1293–1294PubMedCrossRefGoogle Scholar
  6. 6.
    Gioltzoglou T, Cordivari C, Lees A (2005) Problems with botulinum toxin treatment in mitochondrial cytopathy: case report and review of the literature. JNNP 76:1594–1596Google Scholar
  7. 7.
    Girlanda P, Vita G, Messina C (1992) Botulinum toxin therapy: distant effects on neuromuscular transmission and autonomic nervous system. JNNP 55:844–845Google Scholar
  8. 8.
    Crowner B, Torres-Russotto D, Racette B (2010) Systemic weakness after therapeutic injections of botulinum toxin A: a case series and review of the literature. Clin Neuropharmacol 33(5):243–247PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2013

Authors and Affiliations

  • Louisa Kent
    • 1
  • Paul Davies
    • 1
  • Robin Kennett
    • 1
  • Sunil Wimalaratna
    • 1
  • Richard Kerr
    • 1
  • Martin R. Turner
    • 1
  • Kevin Talbot
    • 1
  1. 1.Department of NeurologyJohn Radcliffe HospitalOxfordUK

Personalised recommendations